A - Human Necessities – 23 – L
Patent
A - Human Necessities
23
L
A23L 1/29 (2006.01) A23L 1/308 (2006.01) A61K 31/722 (2006.01)
Patent
CA 2280507
Substance for reduction of absorption of lipids and for reduction of serum cholesterol content in mammals comprises microcrystalline chitosan. The microcrystalline chitosan can be administered orally in food products or in dose units containing a predetermined amount of microcrystalline chitosan. The microcrystalline chitosan has an average particle size not higher than 100 µm.
Cette substance permettant de réduire l'absorption de lipides ainsi que de diminuer le taux de cholestérol sérique chez des mammifères comprend du chitosane microcristallin. Il est possible d'administrer ce chitosane microcristallin par voie orale en l'incorporant à des denrées alimentaires ou en confectionnant des unités posologiques renfermant une quantité prédéterminée dudit chitosane microcristallin. La dimension moyenne des particules du chitosane microcristallin ne dépasse pas 100 µm.
Hakli Harri
Kivekas Olli
Makinen Elina
Struszczyk Henryk
Borden Ladner Gervais Llp
Novasso Oy
LandOfFree
Substance and method for reduction of lipids and cholesterol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substance and method for reduction of lipids and cholesterol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substance and method for reduction of lipids and cholesterol will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732106